Literature DB >> 15133477

Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation.

Susan J Maygarden1, Frank C Detterbeck, William K Funkhouser.   

Abstract

Pathology reports for all lobectomy and pneumonectomy specimens at UNC Hospitals between 1991 and 2000 (n=405) were reviewed for correlation between frozen section and final bronchial margin, gross distance between tumor and margin and tumor type. Frozen section was performed in 268 cases (66%). A total of 243 were true negatives (90.6 %), 16 (6.0%) were true positives, four (1.5%) were false positives and five (1.9%) were false negatives. The site of tumor in true-positive cases was mucosal (11), submucosal (three), lymphatics (one), peribronchial (one). The site of tumor in false-negative cases was submucosal (two), lymphatics (one), peribronchial (two). In 137 cases, no bronchial frozen section was performed; there was one case (0.7%) with positive margin. There was no correlation between final margin positivity and distance between gross tumor and margin. Tumor distance to margin in positive margin cases varied from grossly involved to 3 cm away. There were 72 cases in which wedge resection was performed before lobectomy in which no gross tumor remained in the lobectomy, and in all cases final bronchial margins were negative. In all, 373 of cases (92%) were nonsmall carcinomas. Of these, 10 (2.7%) had positive margins. Tumors other than nonsmall cell carcinoma accounted for a disproportionate number of positive margins. In all, 3/6 of adenoid cystic/mucoepidermoid carcinoma, 1/7 small cell carcinoma and 1/1 lymphoma cases had positive margins. In conclusion, frozen section evaluation of bronchial margins is helpful in central lung tumors. Mucosal tumor is preferentially identified in frozen section. Gross evaluation of margins is problematic, as intramucosal carcinoma or tumor in lymphatics may not be detected, but 3 cm was a 'safe' distance for gross tumor from margin. In lobectomies following wedge resection in which no gross tumor remained, all had negative margins. Salivary gland-type tumors have a high incidence of positive margins, and frozen section is particularly indicated in these tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15133477     DOI: 10.1038/modpathol.3800154

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

1.  Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system.

Authors:  Jialing Zhang; John Rector; John Q Lin; Jonathan H Young; Marta Sans; Nitesh Katta; Noah Giese; Wendong Yu; Chandandeep Nagi; James Suliburk; Jinsong Liu; Alena Bensussan; Rachel J DeHoog; Kyana Y Garza; Benjamin Ludolph; Anna G Sorace; Anum Syed; Aydin Zahedivash; Thomas E Milner; Livia S Eberlin
Journal:  Sci Transl Med       Date:  2017-09-06       Impact factor: 17.956

Review 2.  [Progress of Lung Margin During Sublobar Resection for Early-staged Non-small Cell Lung Cancer].

Authors:  Zongkai Wang; Mingjian Ge
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-06-20

3.  MALDI-ToF mass spectrometry for the rapid diagnosis of cancerous lung nodules.

Authors:  Fabienne Brégeon; Geoffrey Brioude; Florence De Dominicis; Thérèse Atieh; Xavier Benoit D'Journo; Christophe Flaudrops; Jean-Marc Rolain; Didier Raoult; Pascal Alexandre Thomas
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

4.  Prognostic value of molecular events from negative surgical margin of non-small-cell lung cancer.

Authors:  Bangrong Cao; Lin Feng; Dan Lu; Yan Liu; Yu Liu; Suping Guo; Naijun Han; Xiangyang Liu; Yousheng Mao; Jie He; Shujun Cheng; Yanning Gao; Kaitai Zhang
Journal:  Oncotarget       Date:  2016-07-29

5.  Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy.

Authors:  Mengyan Wang; Feng Tang; Xiaobo Pan; Longfang Yao; Xinyi Wang; Yueyue Jing; Jiong Ma; Guifang Wang; Lan Mi
Journal:  BBA Clin       Date:  2017-04-27

6.  Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.

Authors:  Meng Yuan; Yu Men; Jingjing Kang; Xin Sun; Maoyuan Zhao; Yongxing Bao; Xu Yang; Shuang Sun; Zeliang Ma; Jianyang Wang; Lei Deng; Wenqing Wang; Yirui Zhai; Wenyang Liu; Tao Zhang; Xin Wang; Nan Bi; Jima Lv; Jun Liang; Qinfu Feng; Dongfu Chen; Zefen Xiao; Zongmei Zhou; Luhua Wang; Zhouguang Hui
Journal:  Thorac Cancer       Date:  2020-11-27       Impact factor: 3.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.